Wednesday, October 20, 2021
HomeHealthCovaxin from Bharat Biotech has been approved for phase 2/3 trials on...

Covaxin from Bharat Biotech has been approved for phase 2/3 trials on children aged 2 to 18.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs. Covaxin, a COVID-19 vaccine developed by Bharat Biotech of Hyderabad, has received clearance from an expert panel to perform phase 2/3 trials on children aged 2 to 18 years.

On Tuesday, an expert panel (Subject Expert Committee) recommended the drug maker’s anti-COVID vaccine for phase II/III clinical trials on children aged two to eighteen years, according to news agency PTI.

The trial will be conducted in 525 subjects at different locations, including AIIMS Delhi, AIIMS Patna, and Meditrina Institute of Medical Sciences in Nagpur, according to official sources.

The Central Drugs Standard Control Organization’s (CDSCO) Subject Expert Committee on COVID-19 met on Tuesday to discuss Bharat Biotech’s application to perform phase II/III clinical trials in children aged 2 to 18 years to assess the efficacy, reactogenicity, and immunogenicity of Covaxin jabs.

The idea had previously been discussed at an SEC meeting on February 24, and the company had been asked to request a revised clinical trial protocol.

ALSO CHECK: Get a tremendous discount with Firsrtcry Coupon Code and Mamaearth Coupons

Adults are being vaccinated with Covaxin, an indigenously produced vaccine by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR).

The drugmaker announced on Tuesday that it will maintain a steady supply of its COVID-19 vaccine, Covaxin, which has been sent directly to 18 states since May 1.

“Since May 1st, COVAXIN has been sent directly to 18 states. We will continue to supply our #vaccine in a steady supply, unwavering in our efforts “In a tweet, Bharat Biotech said.

Andhra Pradesh, Delhi, Bihar, Gujarat, Haryana, Uttar Pradesh, and West Bengal are among the states, according to the Hyderabad-based company.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Latest

Covaxin News: Good news for those taking the foreign vaccine, may get WHO approval in October

Covaxin May Get Approval Soon: SAGE meeting will be held to give final approval to Covaxin. Apart from the scientists of SAGE, representatives of...

International Flights Update: Big judgment regarding international flight! Flight will not fly till October 31, check details

International Flights Update: The Directorate General of Civil Aviation (DGCA) has issued a circular saying that all scheduled international commercial passenger flights will remain...

EPFO: Don’t be sad if you lose your job! Even after this, Covid Advance will be available, know the rules

PF Covid Advance: To fight the corona epidemic, the government has given the facility to the employed people to take EFP Covid Advance. Now there...

Customers of SBI should be aware of certain important information. Check whether or not Aadhar and PAN should be linked by September 30th

Last date for Aadhar-PAN linking: SBI clients must link their PAN (Permanent Account Number) with their Aadhar card by the end of this month, on...

Coronavirus Could be more dangerous than ever? Now the fear of COVID-22 is haunting the scientists

COVID-22: Experts have claimed that the 'Covid-22' strain can be more lethal than the delta variant and will not be affected by the vaccine....

Subscribe

* indicates required